Brain Stimulation for Working Memory Issues
Trial Summary
What is the purpose of this trial?
Working memory (WM) deficits are a transdiagnostic feature of adolescent psychopathology that substantially contribute to poor clinical and functional outcomes. This proposal will utilize a multimodal neuroscientific approach to investigate whether non-invasive brain stimulation can modulate the neural mechanisms underlying adolescent WM deficits. Directly in line with NIMH priorities, the researchers will identify the contributing roles of prefrontal and parietal regions in WM processes, as well as identify optimal targets and parameters for novel brain-based treatments in adolescent psychopathology. This study is funded by the NIMH-K23
Will I have to stop taking my current medications?
The trial does not require changes to your current medications unless you are taking medications that lower the seizure threshold, which may exclude you from participating. Psychostimulant medications are allowed if deemed safe by the medical review process.
What data supports the effectiveness of the treatment for working memory issues?
Research shows that intermittent theta burst stimulation (iTBS) can improve working memory in healthy individuals by enhancing brain activity patterns, and it has been effective in improving symptoms in conditions like depression and aphasia, suggesting potential benefits for working memory issues.12345
Is intermittent theta burst stimulation (iTBS) safe for humans?
Research shows that intermittent theta burst stimulation (iTBS) is generally safe for humans, with most adverse events being mild and occurring in about 5% of subjects. No serious adverse effects were found in studies involving patients with bipolar depression and healthy participants, but caution is advised due to its novelty.678910
How is intermittent theta burst stimulation (iTBS) different from other treatments for working memory issues?
Intermittent theta burst stimulation (iTBS) is unique because it mimics the brain's natural firing patterns to enhance working memory by targeting the dorsolateral prefrontal cortex, potentially leading to more effective and longer-lasting improvements compared to standard brain stimulation methods.13111213
Eligibility Criteria
This trial is for adolescents aged 13-17 with an IQ over 80 and diagnosed ADHD, who struggle with working memory. They must be fluent in English, able to consent (with parental permission), and have a parent-reported BRIEF-2 Working Memory score above the norm. Exclusions include certain neurological conditions, metal implants affecting the brain or spinal cord, active psychosis or mania, current pregnancy, substance abuse within six months, and other specific medical criteria.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intermittent theta burst stimulation (iTBS) at the left dorsolateral prefrontal cortex (DLPFC) or inferior parietal lobule (IPL) with both active and sham sessions
Follow-up
Participants are monitored for changes in theta-gamma coupling and working memory performance after iTBS sessions
Treatment Details
Interventions
- Active Intermittent Theta Burst Stimulation
- Intermittent Theta Burst Stimulation
- Sham Intermittent Theta Burst Stimulation
Intermittent Theta Burst Stimulation is already approved in United States, European Union for the following indications:
- Treatment-resistant depression
- Treatment-resistant depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
Bradley Hospital
Lead Sponsor